Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net earnings/(loss)	$ 818	$ 358
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	374	347
Impairments and (gain)/loss on disposal of assets, net	2	542
Impairments and loss on sale of other investments	(2)	0
Share-based compensation	60	57
Provision for bad debts	28	21
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables	(253)	(480)
Increase in inventories	(1,967)	(2,449)
Increase/(decrease) in accounts payable	(470)	4,353
Other accrued liabilities and operating items, net	(641)	(1,042)
Net cash provided by/(used in) operating activities	(2,047)	1,707
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired	1,076	0
Proceeds from divestitures, net of cash sold	2	9
Additions to property and equipment	(189)	(206)
Proceeds from disposal of property and equipment	0	2
Purchases of investments	(3)	(2)
Proceeds from investments	2	1
Proceeds from net investment hedge terminations	0	28
Proceeds from short-term investment in time deposit	200	0
Net cash used in investing activities	(1,064)	(168)
Cash flows from financing activities:
Proceeds from long-term obligations, net of issuance costs	2,869	0
Reduction of long-term obligations	(423)	(15)
Net tax proceeds/(withholding) from share-based compensation	(15)	1
Dividends on common shares	(250)	(255)
Purchase of treasury shares, net	(390)	(750)
Net cash provided by/(used in) financing activities	1,791	(1,019)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(3)	1
Net increase/(decrease) in cash and equivalents	(1,323)	521
Cash and equivalents at beginning of period	5,133	4,076
Cash and equivalents at end of period	$ 3,810	$ 4,597